Marburg Hemorrhagic Fever
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
United TherapeuticsMD - Silver Spring
2 programs2
AVI-6003Phase 11 trial
AVI-7288Phase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
United TherapeuticsAVI-7288
United TherapeuticsAVI-6003
Clinical Trials (2)
Total enrollment: 70 patients across 2 trials
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers
Start: May 2013Est. completion: Jan 201440 patients
Phase 1Completed
Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
Start: May 2011Est. completion: Dec 201130 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space